1
Moskowitz David W: Vhl promoter diagnostic polymorphism. Dzgenes, Moskowitz David W, COOK Jennifer E, February 14, 2002: WO/2002/012567

Disclosed is a single nucleotide polymorphism (SNP) associated with colon cancer, hypertension, atherosclerotic peripheral vascular disease due to hypertension, cerebrovascular accident due to hypertension, cataracts due to hypertension, hypertensive cardiomyopathy, myocardial infarction due to hype ...


2
Moskowitz David W: Diagnostic polymorphisms for the ecnos promoter. Dz Genes, Moskowitz David W, COOK Jennifer E, January 31, 2002: WO/2002/008467

Disclosed are single nucleotide polymorphisms (SNPs) associated with breast cancer, lung cancer, prostate cancer, non-insulin dependent diabetes, end stage renal disease due to non-insulin dependent diabetes, hypertension, end stage renal disease due to hypertension, myocardial infarction, colon can ...


3
Moskowitz David W: Diagnostic polymorphisms for the tgf-beta1 promoter. Dz Genes, Moskowitz David W, COOK Jennifer E, January 31, 2002: WO/2002/008468

Disclosed are single nucleotide polymorphisms (SNPs) associated with breast cancer, prostate cancer stage D, colon cancer, lung cancer, hypertension, atherosclerotic peripheral vascular disease due to hypertension, cerebrovascular accident due to hypertension, cataracts due to hypertension, hyperten ...


4
Moskowitz David W: Endothelin-1 promoter polymorphism. Dzgenes, Moskowitz David W, sCOOK Jennifer E, March 21, 2002: WO/2002/022881

Disclosed are single nucleotide polymorphisms (SNPs) associated with hypertension, end stage renal disease due to hypertension, non-insulin dependent diabetes mellitus, end stage renal disease due to non-insulin dependent diabetes mellitus, lung cancer, breast cancer, prostate cancer, colon cancer, ...


5
Moskowitz David W: Tgf$g(b)-rii promoter polymorphisms. Dzgenes, Moskowitz David W, BLOSSER G Harley, November 8, 2001: WO/2001/083828

Disclosed are single nucleotide polymorphisms (SNPs) associated with end stage renal disease, breast cancer, lung cancer, and prostate cancer. Also disclosed are methods for using SNPs to determine susceptibility to these diseases; nucleotide sequences containing SNPs; kits for determining the prese ...


6
Moskowitz David W: Diagnostic polymorphisms of tgf-$g(b)-rii promoter. Dzgenes, Moskowitz David W, BUTLER James E, October 4, 2001: WO/2001/073128

Disclosed are single nucleotide polymorphisms (SNPs) associated with hypertension and end stage renal disease due to hypertension. Also disclosed are methods for using SNPs to determine susceptibility to end stage renal disease and hypertension; nucleotide sequences containing SNPs; kits for determi ...


7
Moskowitz David W: Diagnostic polymorphisms of tgf-beta1 promoter. Dzgenes, Moskowitz David W, BUTLER James E, October 4, 2001: WO/2001/073130

Disclosed are single nucleotide polymorphisms (SNPs) associated with hypertension and end stage renal disease due to hypertension. Also disclosed are methods for using SNPs to determine susceptibility to end stage renal disease and hypertension; nucleotide sequences containing SNPs; kits for determi ...


8
Moskowitz David W: Nitric oxide synthase gene diagnostic polymorphisms. Dzgenes, Moskowitz David W, BUTLER James E, July 26, 2001: WO/2001/053537

Disclosed is a method for determining a genetic predisposition to hypertension, end stage renal disease due to hypertension, non-insulin dependent diabetes mellitus, end stage renal disease due to non-insulin dependent diabetes mellitus, breast cancer, lung cancer or prostate cancer by detecting the ...